Recurrent osteosarcoma with a single pulmonary metastasis: A multi-institutional review

British Journal of Cancer

Volumn 112, Issue 2, 2015, Pages 278-282

  Daw, N C ^a   Chou, A J ^b   Jaffe, N ^a   Rao, B N ^c,d   Billups, C A ^e   Rodriguez Galindo, C ^c,e,f   Meyers, P A ^b   Huh, W W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Chemotherapy; Lung; Metastasectomy; Nodule; Recurrence; Solitary; Thoracotomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MALE; METASTASIS RESECTION; OSTEOSARCOMA; OUTCOME ASSESSMENT; POST RELAPSE EVENT FREE SURVIVAL; POST RELAPSE SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; THORACOTOMY; TREATMENT OUTCOME; BONE NEOPLASMS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; YOUNG ADULT;

ADOLESCENT; BONE NEOPLASMS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84922337299     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.585     Document Type: Article

References (22)

1. Bacci G, Briccoli A, Longhi A, Ferrari S, Mercuri M, Faggioli F, Versari M, Picci P (2005a) Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 44: 748-755.
2. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P (2005b) Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 41: 2836-2845.
3. Bacci G, Mercuri M, Longhi A, Ferrari S, Bertoni F, Versari M, Picci P (2005c) Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer 41: 2079-2085.
4. Briccoli A, Rocca M, Salone M, Bacci G, Ferrari S, Balladelli A, Mercuri M (2005) Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 104: 1721-1725.
5. Carter S, Grimer R, Sneath R, Matthews HR (1991) Results of thoracotomy in osteogenic sarcoma with pulmonary metastases. Thorax 46: 727-731.
6. Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, Parker M, Rusch M, Nagahawatte P, Wu J, Mao S, Boggs K, Mulder H, Yergeau D, Lu C, Ding L, Edmonson M, Qu C, Wang J, Li Y, Navid F, Daw N, Mardis E, Wilson R, Downing JR, Zhang J, Dyer M, St. Jude Children's Research Hospital Washnington University Pediatric Cancer Genome (2014) Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep 7: 104-112.
7. Chi S, Conklin L, Qin J, Meyers P, Huvos A, Healey J, Gorlick R (2004) The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience. Pediatr Blood Cancer 42: 46-51.
8. Crompton B, Goldsby R, Weinberg V, Feren R, O'Donnell R, Ablin A (2006) Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatr Blood Cancer 47: 255-259.
9. Fernandez-Pineda I, Daw N, McCarville B, Emanus L, Rao B, Davidoff A, Shochat S (2012) Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience. J Pediatr Surg 47: 1250-1254.
10. Ferrari S, Briccoli A, Mercuri M, Bertoni F, Picci P, Tienghi A, Del Prever A, Fagioli F, Comandone A, Bacci G (2003) Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol 21: 710-715.
11. Gelderbolm H, Jinks R, Sydes M, Bramwell V, Van Glabbeke M, Grimer R, Hogendoorn P, McTiernan A, Lewis I, Nooij M, Taminiau A, Whelan J (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer 47: 895-902.
12. Harting M, Blakely M, Jaffe N, Cox Jr C, Hayes-Jordan A, Benjamin R, Raymond A, Andrassy R, Lally K (2006) Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg 41: 194-199.
13. Hawkins D, Arndt C (2003) Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 98: 2447-2456.
14. Huvos A (1991) Pathologic assessment of preoperative (neoadjuvant) chemotherapy. In Bone Tumors: Diagnosis, treatment, and prognosis. 2nd edn. W.B. Saunders: Philadelphia, PA, USA.
15. Kempf-Bielack B, Bielack S, Jurgens H, Branscheid D, Berdel W, Exner G, Gobel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 23: 559-568.
16. Leary S, Wozniak A, Billups C, Wu J, McPherson V, Neel M, Rao B, Daw N (2013) Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience. Cancer 119: 2645-2653.
17. Meyer W, Pratt C, PoQuette C, Rao B, Parham D, Marina N, Pappo A, Mahmoud H, Jenkins J, Harper J, Neel M, Fletcher B (2001) Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol 19: 171-182.
18. Meyers P, Gorlick R, Heller G, Casper E, Lane J, Huvos A, Healey J (1998) Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 16: 2452-2458.
19. Meyers P, Schwartz C, Krailo M, Kleinerman E, Betcher D, Bernstein M, Conrad E, Ferguson W, Gebhardt M, Goorin A, Harris M, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H (2005) Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 23: 2004-2011.
20. Satelli A, Mitra A, Cutrera J, Devarie M, Xia X, Ingram D, Dibra D, Somaiah N, Torres K, Ravi V, Ludwig J, Kleinerman E, Li S (2014) Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res 74: 1645-1650.
21. van Geel A, Pastorino U, Jauch K, Judson I, Van Coevorden F, Buesa J, Nielsen O, Boudinet A, Tursz T, Schmitz P (1996) Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 77: 675-682.
22. Whelan J, Jinks R, McTiernan A, Sydes M, Hook J, Trani L, Uscinska B, Bramwell V, Lewis I, Nooij M, Van Glabbeke M, Grimer R, Hogendoorn P, Taminiau A, Gelderblom H (2012) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 23: 1607-1616.